OptiBiotix Health Plc (LON:OPTI – Get Free Report)’s stock price dropped 9.3% during trading on Friday . The stock traded as low as GBX 17.66 ($0.23) and last traded at GBX 17.69 ($0.23). Approximately 552,552 shares traded hands during mid-day trading, an increase of 64% from the average daily volume of 336,786 shares. The stock had previously closed at GBX 19.50 ($0.25).
OptiBiotix Health Price Performance
The company has a current ratio of 6.18, a quick ratio of 7.89 and a debt-to-equity ratio of 4.51. The company has a market capitalization of £17.32 million, a P/E ratio of -651.67 and a beta of 1.71. The business’s fifty day moving average price is GBX 13.61 and its 200-day moving average price is GBX 18.04.
OptiBiotix Health Company Profile
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.
See Also
- Five stocks we like better than OptiBiotix Health
- What Investors Need to Know About Upcoming IPOs
- 3 Enterprise Tech Stocks That Are Viable Takeover Targets in 2025
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Profitably Trade Stocks at 52-Week Highs
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.